Medical care expenditures for hypertension, its complications, and its comorbidities

T A Hodgson1, L Cai

  • 1Office of Analysis, Epidemiology and Health Promotion, National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. THodgson@cdc.gov

Medical Care
|June 19, 2001
PubMed

Insights

Hypertension cost the US $108.8 billion in 2018, with most spending on related conditions, not hypertension itself. Lifestyle changes and medical interventions can significantly reduce these substantial national health expenditures.

Area of Science:

  • Health Economics
  • Public Health
  • Cardiovascular Disease Research

Background:

  • Hypertension is a major public health concern with significant economic implications.
  • Estimating the full medical cost of hypertension requires accounting for direct, indirect, and comorbidity-related expenditures.

Purpose of the Study:

  • To estimate the total, per capita, and per condition medical expenditures attributed to hypertension in the US in 1998.
  • To disaggregate these expenditures by sex, age, and type of health service.
  • To analyze the proportion of spending on hypertension, its complications, and comorbidities.

Main Methods:

  • Utilized national health expenditure data from 1998.
  • Employed attributable risk analysis to determine expenditures for cardiovascular complications and other related conditions.
  • Applied regression analyses to estimate additional costs associated with comorbidities.

Main Results:

  • Total health care spending attributed to hypertension in 1998 was $108.8 billion, representing 12.6% of allocable national health spending.
  • Direct hypertension costs were $22.8 billion, cardiovascular complications $29.7 billion, and other diagnoses $56.4 billion.
  • Per capita spending increased with age, and expenditures were generally higher for females.

Conclusions:

  • The economic burden of hypertension is substantial, with direct treatment costs being only a portion of the total attributed expenditures.
  • Comprehensive cost accounting is crucial for accurately assessing hypertension's economic impact and potential savings from interventions.
  • Lifestyle modifications and medical interventions offer significant opportunities to reduce national health expenditures related to hypertension.
Abstract

Related Concept Videos

Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.